{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T02:48:24Z","timestamp":1792032504106,"version":"4.4.0"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2004,12,28]],"date-time":"2004-12-28T00:00:00Z","timestamp":1104192000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Genet"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1038\/ng1494","type":"journal-article","created":{"date-parts":[[2004,12,28]],"date-time":"2004-12-28T23:36:32Z","timestamp":1104276992000},"page":"19-24","source":"Crossref","is-referenced-by-count":825,"title":["Dysregulation of the TSC-mTOR pathway in human disease"],"prefix":"10.1038","volume":"37","author":[{"given":"Ken","family":"Inoki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael N","family":"Corradetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun-Liang","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2004,12,28]]},"reference":[{"key":"BFng1494_CR1","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1126\/science.1715094","volume":"253","author":"J Heitman","year":"1991","unstructured":"Heitman, J., Movva, N.R. & Hall, M.N. Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Science 253, 905\u2013909 (1991).","journal-title":"Science"},{"key":"BFng1494_CR2","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/369756a0","volume":"369","author":"EJ Brown","year":"1994","unstructured":"Brown, E.J. et al. A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature 369, 756\u2013758 (1994).","journal-title":"Nature"},{"key":"BFng1494_CR3","doi-asserted-by":"crossref","first-page":"12574","DOI":"10.1073\/pnas.91.26.12574","volume":"91","author":"MI Chiu","year":"1994","unstructured":"Chiu, M.I., Katz, H. & Berlin, V. RAPT1, a mammalian homolog of yeast Tor, interacts with the FKBP12\/rapamycin complex. Proc. Natl. Acad. Sci. USA 91, 12574\u201312578 (1994).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFng1494_CR4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0092-8674(94)90570-3","volume":"78","author":"DM Sabatini","year":"1994","unstructured":"Sabatini, D.M., Erdjument-Bromage, H., Lui, M., Tempst, P. & Snyder, S.H. RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs. Cell 78, 35\u201343 (1994).","journal-title":"Cell"},{"key":"BFng1494_CR5","doi-asserted-by":"crossref","first-page":"re15","DOI":"10.1126\/stke.2122003re15","volume":"2003","author":"TE Harris","year":"2003","unstructured":"Harris, T.E. & Lawrence, J.C. Jr. TOR signaling. Sci STKE 2003, re15 (2003).","journal-title":"Sci STKE"},{"key":"BFng1494_CR6","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nrm1018","volume":"4","author":"E Jacinto","year":"2003","unstructured":"Jacinto, E. & Hall, M.N. Tor signalling in bugs, brain and brawn. Nat. Rev. Mol. Cell Biol. 4, 117\u2013126 (2003).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"BFng1494_CR7","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.cub.2004.06.054","volume":"14","author":"D Sarbassov dos","year":"2004","unstructured":"Sarbassov dos, D. et al. Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr. Biol. 14, 1296\u20131302 (2004).","journal-title":"Curr. Biol."},{"key":"BFng1494_CR8","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0092-8674(02)00833-4","volume":"110","author":"K Hara","year":"2002","unstructured":"Hara, K. et al. Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. Cell 110, 177\u2013189 (2002).","journal-title":"Cell"},{"key":"BFng1494_CR9","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0092-8674(02)00808-5","volume":"110","author":"DH Kim","year":"2002","unstructured":"Kim, D.H. et al. mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 110, 163\u2013175 (2002).","journal-title":"Cell"},{"key":"BFng1494_CR10","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S1097-2765(02)00636-6","volume":"10","author":"R Loewith","year":"2002","unstructured":"Loewith, R. et al. Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control. Mol. Cell 10, 457\u2013468 (2002).","journal-title":"Mol. Cell"},{"key":"BFng1494_CR11","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/978-3-642-56688-2_5","volume":"26","author":"J Avruch","year":"2001","unstructured":"Avruch, J., Belham, C., Weng, Q., Hara, K. & Yonezawa, K. The p70 S6 kinase integrates nutrient and growth signals to control translational capacity. Prog. Mol. Subcell. Biol. 26, 115\u2013154 (2001).","journal-title":"Prog. Mol. Subcell. Biol."},{"key":"BFng1494_CR12","doi-asserted-by":"crossref","first-page":"6321","DOI":"10.1046\/j.1432-1327.2000.01719.x","volume":"267","author":"O Meyuhas","year":"2000","unstructured":"Meyuhas, O. Synthesis of the translational apparatus is regulated at the translational level. Eur. J. Biochem. 267, 6321\u20136330 (2000).","journal-title":"Eur. J. Biochem."},{"key":"BFng1494_CR13","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1146\/annurev.biochem.68.1.913","volume":"68","author":"AC Gingras","year":"1999","unstructured":"Gingras, A.C., Raught, B. & Sonenberg, N. eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. Annu. Rev. Biochem. 68, 913\u2013963 (1999).","journal-title":"Annu. Rev. Biochem."},{"key":"BFng1494_CR14","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1038\/sj.onc.1207549","volume":"23","author":"Y Mamane","year":"2004","unstructured":"Mamane, Y. et al. eIF4E--from translation to transformation. Oncogene 23, 3172\u20133179 (2004).","journal-title":"Oncogene"},{"key":"BFng1494_CR15","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1128\/MCB.24.1.200-216.2004","volume":"24","author":"DC Fingar","year":"2004","unstructured":"Fingar, D.C. et al. mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1\/eukaryotic translation initiation factor 4E. Mol. Cell. Biol. 24, 200\u2013216 (2004).","journal-title":"Mol. Cell. Biol."},{"key":"BFng1494_CR16","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0092-8674(01)00333-6","volume":"105","author":"CJ Potter","year":"2001","unstructured":"Potter, C.J., Huang, H. & Xu, T. Drosophila Tsc1 functions with Tsc2 to antagonize insulin signaling in regulating cell growth, cell proliferation, and organ size. Cell 105, 357\u2013368 (2001).","journal-title":"Cell"},{"key":"BFng1494_CR17","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0092-8674(01)00332-4","volume":"105","author":"N Tapon","year":"2001","unstructured":"Tapon, N., Ito, N., Dickson, B.J., Treisman, J.E. & Hariharan, I.K. The Drosophila tuberous sclerosis complex gene homologs restrict cell growth and cell proliferation. Cell 105, 345\u2013355 (2001).","journal-title":"Cell"},{"key":"BFng1494_CR18","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1101\/gad.901101","volume":"15","author":"X Gao","year":"2001","unstructured":"Gao, X. & Pan, D. TSC1 and TSC2 tumor suppressors antagonize insulin signaling in cell growth. Genes Dev. 15, 1383\u20131392 (2001).","journal-title":"Genes Dev."},{"key":"BFng1494_CR19","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/ncb995","volume":"5","author":"H Stocker","year":"2003","unstructured":"Stocker, H. et al. Rheb is an essential regulator of S6K in controlling cell growth in Drosophila. Nat. Cell Biol. 5, 559\u2013565 (2003).","journal-title":"Nat. Cell Biol."},{"key":"BFng1494_CR20","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/ncb996","volume":"5","author":"LJ Saucedo","year":"2003","unstructured":"Saucedo, L.J. et al. Rheb promotes cell growth as a component of the insulin\/TOR signalling network. Nat. Cell Biol. 5, 566\u2013571 (2003).","journal-title":"Nat. Cell Biol."},{"key":"BFng1494_CR21","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S1097-2765(02)00568-3","volume":"10","author":"BD Manning","year":"2002","unstructured":"Manning, B.D., Tee, A.R., Logsdon, M.N., Blenis, J. & Cantley, L.C. Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase\/akt pathway. Mol. Cell 10, 151\u2013162 (2002).","journal-title":"Mol. Cell"},{"key":"BFng1494_CR22","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/ncb839","volume":"4","author":"K Inoki","year":"2002","unstructured":"Inoki, K., Li, Y., Zhu, T., Wu, J. & Guan, K.L. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat. Cell Biol. 4, 648\u2013657 (2002).","journal-title":"Nat. Cell Biol."},{"key":"BFng1494_CR23","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/ncb840","volume":"4","author":"CJ Potter","year":"2002","unstructured":"Potter, C.J., Pedraza, L.G. & Xu, T. Akt regulates growth by directly phosphorylating Tsc2. Nat. Cell Biol. 4, 658\u2013665 (2002).","journal-title":"Nat. Cell Biol."},{"key":"BFng1494_CR24","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/ncb999","volume":"5","author":"Y Zhang","year":"2003","unstructured":"Zhang, Y. et al. Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins. Nat. Cell Biol. 5, 578\u2013581 (2003).","journal-title":"Nat. Cell Biol."},{"key":"BFng1494_CR25","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/S1097-2765(03)00220-X","volume":"11","author":"A Garami","year":"2003","unstructured":"Garami, A. et al. Insulin activation of Rheb, a mediator of mTOR\/S6K\/4E-BP signaling, is inhibited by TSC1 and 2. Mol. Cell 11, 1457\u20131466 (2003).","journal-title":"Mol. Cell"},{"key":"BFng1494_CR26","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1101\/gad.1110003","volume":"17","author":"K Inoki","year":"2003","unstructured":"Inoki, K., Li, Y., Xu, T. & Guan, K.L. Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes Dev. 17, 1829\u20131834 (2003).","journal-title":"Genes Dev."},{"key":"BFng1494_CR27","doi-asserted-by":"crossref","first-page":"30958","DOI":"10.1074\/jbc.M202678200","volume":"277","author":"EA Goncharova","year":"2002","unstructured":"Goncharova, E.A. et al. Tuberin regulates p70 S6 kinase activation and ribosomal protein S6 phosphorylation. J. Biol. Chem. 277, 30958\u201330967 (2002).","journal-title":"J. Biol. Chem."},{"key":"BFng1494_CR28","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/hmg\/11.5.525","volume":"11","author":"DJ Kwiatkowski","year":"2002","unstructured":"Kwiatkowski, D.J. et al. A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells. Hum. Mol. Genet. 11, 525\u2013534 (2002).","journal-title":"Hum. Mol. Genet."},{"key":"BFng1494_CR29","doi-asserted-by":"crossref","first-page":"10320","DOI":"10.1073\/pnas.171060098","volume":"98","author":"K Podsypanina","year":"2001","unstructured":"Podsypanina, K. et al. An inhibitor of mTOR reduces neoplasia and normalizes p70\/S6 kinase activity in Pten+\/\u2212 mice. Proc. Natl. Acad. Sci. USA 98, 10320\u201310325 (2001).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFng1494_CR30","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/ncb847","volume":"4","author":"X Gao","year":"2002","unstructured":"Gao, X. et al. Tsc tumour suppressor proteins antagonize amino-acid-TOR signalling. Nat. Cell Biol. 4, 699\u2013704 (2002).","journal-title":"Nat. Cell Biol."},{"key":"BFng1494_CR31","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1126\/science.1063518","volume":"294","author":"PB Dennis","year":"2001","unstructured":"Dennis, P.B. et al. Mammalian TOR: a homeostatic ATP sensor. Science 294, 1102\u20131105 (2001).","journal-title":"Science"},{"key":"BFng1494_CR32","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1146\/annurev.biochem.67.1.821","volume":"67","author":"DG Hardie","year":"1998","unstructured":"Hardie, D.G., Carling, D. & Carlson, M. The AMP-activated\/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell? Annu. Rev. Biochem. 67, 821\u2013855 (1998).","journal-title":"Annu. Rev. Biochem."},{"key":"BFng1494_CR33","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0092-8674(03)00929-2","volume":"115","author":"K Inoki","year":"2003","unstructured":"Inoki, K., Zhu, T. & Guan, K.L. TSC2 mediates cellular energy response to control cell growth and survival. Cell 115, 577\u2013590 (2003).","journal-title":"Cell"},{"key":"BFng1494_CR34","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1475-4924-2-28","volume":"2","author":"SA Hawley","year":"2003","unstructured":"Hawley, S.A. et al. Complexes between the LKB1 tumor suppressor, STRADalpha\/beta and MO25alpha\/beta are upstream kinases in the AMP-activated protein kinase cascade. J. Biol. 2, 28 (2003).","journal-title":"J. Biol."},{"key":"BFng1494_CR35","doi-asserted-by":"crossref","first-page":"8839","DOI":"10.1073\/pnas.1533136100","volume":"100","author":"SP Hong","year":"2003","unstructured":"Hong, S.P., Leiper, F.C., Woods, A., Carling, D. & Carlson, M. Activation of yeast Snf1 and mammalian AMP-activated protein kinase by upstream kinases. Proc. Natl. Acad. Sci. USA 100, 8839\u20138843 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFng1494_CR36","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1016\/j.cub.2003.10.031","volume":"13","author":"A Woods","year":"2003","unstructured":"Woods, A. et al. LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr. Biol. 13, 2004\u20132008 (2003).","journal-title":"Curr. Biol."},{"key":"BFng1494_CR37","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1101\/gad.1199104","volume":"18","author":"MN Corradetti","year":"2004","unstructured":"Corradetti, M.N., Inoki, K., Bardeesy, N., DePinho, R.A. & Guan, K.L. Regulation of the TSC pathway by LKB1: evidence of a molecular link between tuberous sclerosis complex and Peutz-Jeghers syndrome. Genes Dev. 18, 1533\u20131538 (2004).","journal-title":"Genes Dev."},{"key":"BFng1494_CR38","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ccr.2004.06.007","volume":"6","author":"RJ Shaw","year":"2004","unstructured":"Shaw, R.J. et al. The LKB1 tumor suppressor negatively regulates mTOR signaling. Cancer Cell 6, 91\u201399 (2004).","journal-title":"Cancer Cell"},{"key":"BFng1494_CR39","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1073\/pnas.0308061100","volume":"101","author":"RJ Shaw","year":"2004","unstructured":"Shaw, R.J. et al. The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. Proc. Natl. Acad. Sci. USA 101, 3329\u20133335 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFng1494_CR40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.cellbio.15.1.1","volume":"15","author":"DJ Klionsky","year":"1999","unstructured":"Klionsky, D.J. & Ohsumi, Y. Vacuolar import of proteins and organelles from the cytoplasm. Annu. Rev. Cell Dev. Biol. 15, 1\u201332 (1999).","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"BFng1494_CR41","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1038\/sj.onc.1207521","volume":"23","author":"D Gozuacik","year":"2004","unstructured":"Gozuacik, D. & Kimchi, A. Autophagy as a cell death and tumor suppressor mechanism. Oncogene 23, 2891\u20132906 (2004).","journal-title":"Oncogene"},{"key":"BFng1494_CR42","first-page":"73","volume":"279","author":"Y Kamada","year":"2004","unstructured":"Kamada, Y., Sekito, T. & Ohsumi, Y. Autophagy in yeast: a TOR-mediated response to nutrient starvation. Curr. Top. Microbiol. Immunol. 279, 73\u201384 (2004).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"BFng1494_CR43","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/ng1362","volume":"36","author":"B Ravikumar","year":"2004","unstructured":"Ravikumar, B. et al. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat. Genet. 36, 585\u2013595 (2004).","journal-title":"Nat. Genet."},{"key":"BFng1494_CR44","first-page":"329","volume":"20","author":"J van der Hoeve","year":"1920","unstructured":"van der Hoeve, J. Eye symptoms in tuberous sclerosis of the brain. Trans. Ophthalmol. Soc. UK 20, 329\u2013334 (1920).","journal-title":"Trans. Ophthalmol. Soc. UK"},{"key":"BFng1494_CR45","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/jnci\/92.7.530","volume":"92","author":"M Tucker","year":"2000","unstructured":"Tucker, M., Goldstein, A., Dean, M. & Knudson, A. National Cancer Institute Workshop Report: the phakomatoses revisited. J. Natl. Cancer Inst. 92, 530\u2013533 (2000).","journal-title":"J. Natl. Cancer Inst."},{"key":"BFng1494_CR46","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1126\/science.277.5327.805","volume":"277","author":"M van Slegtenhorst","year":"1997","unstructured":"van Slegtenhorst, M. et al. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 277, 805\u2013808 (1997).","journal-title":"Science"},{"key":"BFng1494_CR47","doi-asserted-by":"crossref","unstructured":"The European Chromosome 16 Tuberous Sclerosis Consortium. Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 75, 1305\u20131315 (1993).","DOI":"10.1016\/0092-8674(93)90618-Z"},{"key":"BFng1494_CR48","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1086\/321972","volume":"69","author":"Y Niida","year":"2001","unstructured":"Niida, Y. et al. Survey of somatic mutations in tuberous sclerosis complex (TSC) hamartomas suggests different genetic mechanisms for pathogenesis of TSC lesions. Am. J. Hum. Genet. 69, 493\u2013503 (2001).","journal-title":"Am. J. Hum. Genet."},{"key":"BFng1494_CR49","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1034\/j.1399-0004.2002.620501.x","volume":"62","author":"T Tucker","year":"2002","unstructured":"Tucker, T. & Friedman, J.M. Pathogenesis of hereditary tumors: beyond the \u201ctwo-hit\u201d hypothesis. Clin. Genet. 62, 345\u2013357 (2002).","journal-title":"Clin. Genet."},{"key":"BFng1494_CR50","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/S0140-6736(03)13044-9","volume":"361","author":"N El-Hashemite","year":"2003","unstructured":"El-Hashemite, N., Zhang, H., Henske, E.P. & Kwiatkowski, D.J. Mutation in TSC2 and activation of mammalian target of rapamycin signalling pathway in renal angiomyolipoma. Lancet 361, 1348\u20131349 (2003).","journal-title":"Lancet"},{"key":"BFng1494_CR51","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1046\/j.1469-1809.2003.00012.x","volume":"67","author":"DJ Kwiatkowski","year":"2003","unstructured":"Kwiatkowski, D.J. Tuberous sclerosis: from tubers to mTOR. Ann. Hum. Genet. 67, 87\u201396 (2003).","journal-title":"Ann. Hum. Genet."},{"key":"BFng1494_CR52","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S1535-6108(03)00275-7","volume":"4","author":"CL Sawyers","year":"2003","unstructured":"Sawyers, C.L. Will mTOR inhibitors make it as cancer drugs? Cancer Cell 4, 343\u2013348 (2003).","journal-title":"Cancer Cell"},{"key":"BFng1494_CR53","first-page":"5645","volume":"62","author":"HL Kenerson","year":"2002","unstructured":"Kenerson, H.L., Aicher, L.D., True, L.D. & Yeung, R.S. Activated mammalian target of rapamycin pathway in the pathogenesis of tuberous sclerosis complex renal tumors. Cancer Res. 62, 5645\u20135650 (2002).","journal-title":"Cancer Res."},{"key":"BFng1494_CR54","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/humu.10257","volume":"22","author":"C Eng","year":"2003","unstructured":"Eng, C. PTEN: one gene, many syndromes. Hum. Mutat. 22, 183\u2013198 (2003).","journal-title":"Hum. Mutat."},{"key":"BFng1494_CR55","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1146\/annurev.biochem.70.1.247","volume":"70","author":"T Maehama","year":"2001","unstructured":"Maehama, T., Taylor, G.S. & Dixon, J.E. PTEN and MYOTUBULARIN: Novel Phosphoinositide Phosphatases. Annu. Rev. Biochem. 70, 247\u2013279 (2001).","journal-title":"Annu. Rev. Biochem."},{"key":"BFng1494_CR56","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1086\/377109","volume":"73","author":"XP Zhou","year":"2003","unstructured":"Zhou, X.P. et al. Germline PTEN promoter mutations and deletions in Cowden\/Bannayan-Riley-Ruvalcaba syndrome result in aberrant PTEN protein and dysregulation of the phosphoinositol-3-kinase\/Akt pathway. Am. J. Hum. Genet. 73, 404\u2013411 (2003).","journal-title":"Am. J. Hum. Genet."},{"key":"BFng1494_CR57","doi-asserted-by":"crossref","first-page":"10314","DOI":"10.1073\/pnas.171076798","volume":"98","author":"MS Neshat","year":"2001","unstructured":"Neshat, M.S. et al. Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP\/mTOR. Proc. Natl. Acad. Sci. USA 98, 10314\u201310319 (2001).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFng1494_CR58","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/nm1052","volume":"10","author":"PK Majumder","year":"2004","unstructured":"Majumder, P.K. et al. mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways. Nat. Med. 10, 594\u2013601 (2004).","journal-title":"Nat. Med."},{"key":"BFng1494_CR59","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/0016-5085(88)90628-2","volume":"94","author":"G Devroede","year":"1988","unstructured":"Devroede, G., Lemieux, B., Masse, S., Lamarche, J. & Herman, P.S. Colonic hamartomas in tuberous sclerosis. Gastroenterology 94, 182\u2013188 (1988).","journal-title":"Gastroenterology"},{"key":"BFng1494_CR60","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1093\/oso\/9780195122107.001.0001","volume-title":"Tuberous Sclerosis Complex","author":"MR Gomez","year":"1999","unstructured":"Gomez, M.R., Sampson, J. & Whittemore, V.H. Tuberous Sclerosis Complex 340 (Oxford University Press, Oxford, 1999)."},{"key":"BFng1494_CR61","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.0009-9163.2004.00266.x","volume":"66","author":"I Hernan","year":"2004","unstructured":"Hernan, I. et al. De novo germline mutation in the serine-threonine kinase STK11\/LKB1 gene associated with Peutz-Jeghers syndrome. Clin. Genet. 66, 58\u201362 (2004).","journal-title":"Clin. Genet."},{"key":"BFng1494_CR62","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1136\/jcp.54.2.126","volume":"54","author":"MM Entius","year":"2001","unstructured":"Entius, M.M. et al. Molecular genetic alterations in hamartomatous polyps and carcinomas of patients with Peutz-Jeghers syndrome. J. Clin. Pathol. 54, 126\u2013131 (2001).","journal-title":"J. Clin. Pathol."},{"key":"BFng1494_CR63","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nature01045","volume":"419","author":"N Bardeesy","year":"2002","unstructured":"Bardeesy, N. et al. Loss of the Lkb1 tumour suppressor provokes intestinal polyposis but resistance to transformation. Nature 419, 162\u2013167 (2002).","journal-title":"Nature"},{"key":"BFng1494_CR64","first-page":"2261","volume":"62","author":"H Miyoshi","year":"2002","unstructured":"Miyoshi, H. et al. Gastrointestinal hamartomatous polyposis in Lkb1 heterozygous knockout mice. Cancer Res. 62, 2261\u20132266 (2002).","journal-title":"Cancer Res."},{"key":"BFng1494_CR65","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0733-8619(03)00004-5","volume":"21","author":"RS Kandt","year":"2003","unstructured":"Kandt, R.S. Tuberous sclerosis complex and neurofibromatosis type 1: the two most common neurocutaneous diseases. Neurol. Clin. 21, 983\u20131004 (2003).","journal-title":"Neurol. Clin."},{"key":"BFng1494_CR66","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0092-8674(01)00245-8","volume":"104","author":"K Cichowski","year":"2001","unstructured":"Cichowski, K. & Jacks, T. NF1 tumor suppressor gene function: narrowing the GAP. Cell 104, 593\u2013604 (2001).","journal-title":"Cell"},{"key":"BFng1494_CR67","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1038\/sj.onc.1207539","volume":"23","author":"S Furuta","year":"2004","unstructured":"Furuta, S., Hidaka, E., Ogata, A., Yokota, S. & Kamata, T. Ras is involved in the negative control of autophagy through the class I PI3-kinase. Oncogene 23, 3898\u20133904 (2004).","journal-title":"Oncogene"},{"key":"BFng1494_CR68","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1158\/0008-5472.CAN-03-1859","volume":"64","author":"J Shao","year":"2004","unstructured":"Shao, J., Evers, B.M. & Sheng, H. Roles of phosphatidylinositol 3\u2032-kinase and mammalian target of rapamycin\/p70 ribosomal protein S6 kinase in K-Ras-mediated transformation of intestinal epithelial cells. Cancer Res. 64, 229\u2013235 (2004).","journal-title":"Cancer Res."},{"key":"BFng1494_CR69","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1097\/01.ASN.0000092803.69761.41","volume":"14","author":"WG Kaelin Jr.","year":"2003","unstructured":"Kaelin, W.G. Jr. The von Hippel-Lindau gene, kidney cancer, and oxygen sensing. J. Am. Soc. Nephrol. 14, 2703\u20132711 (2003).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFng1494_CR70","first-page":"5173","volume":"63","author":"N El-Hashemite","year":"2003","unstructured":"El-Hashemite, N., Walker, V., Zhang, H. & Kwiatkowski, D.J. Loss of Tsc1 or Tsc2 induces vascular endothelial growth factor production through mammalian target of rapamycin. Cancer Res. 63, 5173\u20135177 (2003).","journal-title":"Cancer Res."},{"key":"BFng1494_CR71","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1535-6108(03)00187-9","volume":"4","author":"JB Brugarolas","year":"2003","unstructured":"Brugarolas, J.B., Vazquez, F., Reddy, A., Sellers, W.R. & Kaelin, W.G., Jr. TSC2 regulates VEGF through mTOR-dependent and -independent pathways. Cancer Cell 4, 147\u2013158 (2003).","journal-title":"Cancer Cell"},{"key":"BFng1494_CR72","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1126\/science.1350108","volume":"256","author":"LK Su","year":"1992","unstructured":"Su, L.K. et al. Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 256, 668\u2013670 (1992).","journal-title":"Science"},{"key":"BFng1494_CR73","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/hmg\/10.7.721","volume":"10","author":"NS Fearnhead","year":"2001","unstructured":"Fearnhead, N.S., Britton, M.P. & Bodmer, W.F. The ABC of APC. Hum. Mol. Genet. 10, 721\u2013733 (2001).","journal-title":"Hum. Mol. Genet."},{"key":"BFng1494_CR74","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1074\/jbc.M309999200","volume":"279","author":"JF Gera","year":"2004","unstructured":"Gera, J.F. et al. AKT activity determines sensitivity to mammalian target of rapamycin (mTOR) inhibitors by regulating cyclin D1 and c-myc expression. J. Biol. Chem. 279, 2737\u20132746 (2004).","journal-title":"J. Biol. Chem."},{"key":"BFng1494_CR75","doi-asserted-by":"crossref","first-page":"5947","DOI":"10.1074\/jbc.C200473200","volume":"278","author":"BC Mak","year":"2003","unstructured":"Mak, B.C., Takemaru, K., Kenerson, H.L., Moon, R.T. & Yeung, R.S. The tuberin-hamartin complex negatively regulates Beta -catenin signaling activity. J. Biol. Chem. 278, 5947\u20135951 (2003).","journal-title":"J. Biol. Chem."},{"key":"BFng1494_CR76","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1126\/science.280.5366.1086","volume":"280","author":"JR Howe","year":"1998","unstructured":"Howe, J.R. et al. Mutations in the SMAD4\/DPC4 gene in juvenile polyposis. Science 280, 1086\u20131088 (1998).","journal-title":"Science"},{"key":"BFng1494_CR77","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1086\/323703","volume":"69","author":"XP Zhou","year":"2001","unstructured":"Zhou, X.P. et al. Germline mutations in BMPR1A\/ALK3 cause a subset of cases of juvenile polyposis syndrome and of Cowden and Bannayan-Riley-Ruvalcaba syndromes. Am. J. Hum. Genet. 69, 704\u2013711 (2001).","journal-title":"Am. J. Hum. Genet."},{"key":"BFng1494_CR78","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/ajmg.a.20477","volume":"122A","author":"C Eng","year":"2003","unstructured":"Eng, C. Constipation, polyps, or cancer? Let PTEN predict your future. Am. J. Med. Genet. 122A, 315\u2013322 (2003).","journal-title":"Am. J. Med. Genet."},{"key":"BFng1494_CR79","doi-asserted-by":"crossref","first-page":"25605","DOI":"10.1074\/jbc.M402790200","volume":"279","author":"MC Birchenall-Roberts","year":"2004","unstructured":"Birchenall-Roberts, M.C. et al. Tuberous sclerosis complex 2 gene product interacts with human SMAD proteins. A molecular link of two tumor suppressor pathways. J. Biol. Chem. 279, 25605\u201325613 (2004).","journal-title":"J. Biol. Chem."},{"key":"BFng1494_CR80","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1083\/jcb.200211021","volume":"161","author":"P Rajan","year":"2003","unstructured":"Rajan, P., Panchision, D.M., Newell, L.F. & McKay, R.D. BMPs signal alternately through a SMAD or FRAP-STAT pathway to regulate fate choice in CNS stem cells. J. Cell Biol. 161, 911\u2013921 (2003).","journal-title":"J. Cell Biol."},{"key":"BFng1494_CR81","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/ng1430","volume":"36","author":"XC He","year":"2004","unstructured":"He, X.C. et al. BMP signaling inhibits intestinal stem cell self-renewal through suppression of Wnt-beta-catenin signaling. Nat. Genet. 36, 1117\u20131121 (2004).","journal-title":"Nat. Genet."},{"key":"BFng1494_CR82","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/79238","volume":"26","author":"LS Kirschner","year":"2000","unstructured":"Kirschner, L.S. et al. Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex. Nat. Genet. 26, 89\u201392 (2000).","journal-title":"Nat. Genet."},{"key":"BFng1494_CR83","first-page":"334","volume":"54","author":"CA Stratakis","year":"2000","unstructured":"Stratakis, C.A. Genetics of Peutz-Jeghers syndrome, Carney complex and other familial lentiginoses. Horm. Res. 54, 334\u2013343 (2000).","journal-title":"Horm. Res."},{"key":"BFng1494_CR84","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1535-6108(02)00104-6","volume":"2","author":"ML Nickerson","year":"2002","unstructured":"Nickerson, M.L. et al. Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dube syndrome. Cancer Cell 2, 157\u2013164 (2002).","journal-title":"Cancer Cell"},{"key":"BFng1494_CR85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1053\/rmed.2001.1207","volume":"96","author":"E Hancock","year":"2002","unstructured":"Hancock, E. & Osborne, J. Lymphangioleiomyomatosis: a review of the literature. Respir. Med. 96, 1\u20136 (2002).","journal-title":"Respir. Med."},{"key":"BFng1494_CR86","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nrc1364","volume":"4","author":"CP Pavlovich","year":"2004","unstructured":"Pavlovich, C.P. & Schmidt, L.S. Searching for the hereditary causes of renal-cell carcinoma. Nat. Rev. Cancer 4, 381\u2013393 (2004).","journal-title":"Nat. Rev. Cancer"},{"key":"BFng1494_CR87","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1073\/pnas.0308071100","volume":"101","author":"K Okimoto","year":"2004","unstructured":"Okimoto, K. et al. A germ-line insertion in the Birt-Hogg-Dube (BHD) gene gives rise to the Nihon rat model of inherited renal cancer. Proc. Natl. Acad. Sci. USA 101, 2023\u20132027 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFng1494_CR88","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1083\/jcb.200403069","volume":"166","author":"LS Harrington","year":"2004","unstructured":"Harrington, L.S. et al. The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins. J. Cell Biol. 166, 213\u2013223 (2004).","journal-title":"J. Cell Biol."},{"key":"BFng1494_CR89","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.cub.2004.08.026","volume":"14","author":"OJ Shah","year":"2004","unstructured":"Shah, O.J., Wang, Z. & Hunter, T. Inappropriate activation of the TSC\/Rheb\/mTOR\/S6K cassette induces IRS1\/2 depletion, insulin resistance, and cell survival deficiencies. Curr. Biol. 14, 1650\u20131656 (2004).","journal-title":"Curr. Biol."},{"key":"BFng1494_CR90","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/nature02866","volume":"431","author":"SH Um","year":"2004","unstructured":"Um, S.H. et al. Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. Nature 431, 200\u2013205 (2004).","journal-title":"Nature"},{"key":"BFng1494_CR91","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1172\/JCI200317222","volume":"112","author":"H Zhang","year":"2003","unstructured":"Zhang, H. et al. Loss of Tsc1\/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR. J. Clin. Invest. 112, 1223\u20131233 (2003).","journal-title":"J. Clin. Invest."},{"key":"BFng1494_CR92","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1161\/01.CIR.0000057979.36322.88","volume":"107","author":"T Shioi","year":"2003","unstructured":"Shioi, T. et al. Rapamycin attenuates load-induced cardiac hypertrophy in mice. Circulation 107, 1664\u20131670 (2003).","journal-title":"Circulation"},{"key":"BFng1494_CR93","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/hmg\/10.11.1215","volume":"10","author":"E Blair","year":"2001","unstructured":"Blair, E. et al. Mutations in the gamma(2) subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis. Hum. Mol. Genet. 10, 1215\u20131220 (2001).","journal-title":"Hum. Mol. Genet."},{"key":"BFng1494_CR94","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1056\/NEJM200106143442403","volume":"344","author":"MH Gollob","year":"2001","unstructured":"Gollob, M.H. et al. Identification of a gene responsible for familial Wolff-Parkinson-White syndrome. N. Engl. J. Med. 344, 1823\u20131831 (2001).","journal-title":"N. Engl. J. Med."},{"key":"BFng1494_CR95","doi-asserted-by":"crossref","first-page":"51017","DOI":"10.1074\/jbc.M207093200","volume":"277","author":"T Daniel","year":"2002","unstructured":"Daniel, T. & Carling, D. Functional analysis of mutations in the gamma 2 subunit of AMP-activated protein kinase associated with cardiac hypertrophy and Wolff-Parkinson-White syndrome. J. Biol. Chem. 277, 51017\u201351024 (2002).","journal-title":"J. Biol. Chem."},{"key":"BFng1494_CR96","doi-asserted-by":"crossref","first-page":"32771","DOI":"10.1074\/jbc.M403528200","volume":"279","author":"AY Chan","year":"2004","unstructured":"Chan, A.Y., Soltys, C.L., Young, M.E., Proud, C.G. & Dyck, J.R. Activation of AMP-activated protein kinase inhibits protein synthesis associated with hypertrophy in the cardiac myocyte. J. Biol. Chem. 279, 32771\u201332779 (2004).","journal-title":"J. Biol. Chem."},{"key":"BFng1494_CR97","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1146\/annurev.immunol.14.1.483","volume":"14","author":"RT Abraham","year":"1996","unstructured":"Abraham, R.T. & Wiederrecht, G.J. Immunopharmacology of rapamycin. Annu. Rev. Immunol. 14, 483\u2013510 (1996).","journal-title":"Annu. Rev. Immunol."},{"key":"BFng1494_CR98","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1097\/00001573-200209000-00012","volume":"17","author":"L Garza","year":"2002","unstructured":"Garza, L., Aude, Y.W. & Saucedo, J.F. Can we prevent in-stent restenosis? Curr. Opin. Cardiol. 17, 518\u2013525 (2002).","journal-title":"Curr. Opin. Cardiol."},{"key":"BFng1494_CR99","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S1471-4892(03)00071-7","volume":"3","author":"S Huang","year":"2003","unstructured":"Huang, S. & Houghton, P.J. Targeting mTOR signaling for cancer therapy. Curr. Opin. Pharmacol. 3, 371\u2013377 (2003).","journal-title":"Curr. Opin. Pharmacol."},{"key":"BFng1494_CR100","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nrc1362","volume":"4","author":"MA Bjornsti","year":"2004","unstructured":"Bjornsti, M.A. & Houghton, P.J. The TOR pathway: a target for cancer therapy. Nat. Rev. Cancer 4, 335\u2013348 (2004).","journal-title":"Nat. Rev. Cancer"}],"container-title":["Nature Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ng1494.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ng1494","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ng1494.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T15:32:53Z","timestamp":1705505573000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ng1494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12,28]]},"references-count":100,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["BFng1494"],"URL":"https:\/\/doi.org\/10.1038\/ng1494","relation":{},"ISSN":["1061-4036","1546-1718"],"issn-type":[{"value":"1061-4036","type":"print"},{"value":"1546-1718","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,12,28]]}}}